香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全 部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 China Golden Classic Group Limited 中 國 金 典 集 團 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：8281） 截 至 二 零 二 三 年 六 月 三 十 日 止 六 個 月 之 中 期 業 績 公 告 香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為相比起其他在聯交所上市的公司帶有較高投資風險的中小 型公司提供一個上市的市場。有意投資的人士應了解投資於該等公司的潛在 風險，並應經過審慎周詳的考慮後方作出投資決定。 由於在GEM上市的公司普遍為中小型公司，在GEM買賣的證券可能會較於聯 交所主板買賣的證券承受較大的市場波動風險，同時無法保證在GEM買賣的 證券會有高流通量的市場。 本公告乃根據GEM證券上市規則（「GEM上市規則」）之規定提供有關中國金典集 團有限公司（「本公司」，連同其附屬公司統稱「本集團」）之資料。本公司各董事 ...

Financial Performance - The company reported a revenue of RMB 66,018,000 for the first quarter of 2023, an increase of 10.8% compared to RMB 59,724,000 in the same period last year[4]. - Gross profit for the first quarter of 2023 was RMB 24,343,000, up 17.5% from RMB 20,764,000 year-on-year[4]. - The company achieved a net profit of RMB 1,031,000 in Q1 2023, a significant improvement from a net loss of RMB 4,072,000 in Q1 2022[4]. - Basic and diluted earnings per share for the first quarter of 2023 were RMB 0.09, compared to a loss per share of RMB 0.41 in the previous year[4]. - For the three months ended March 31, 2023, the total revenue was approximately RMB 66.0 million, an increase of about 10.5% compared to RMB 59.7 million for the same period last year[27]. - The net profit for the same period was approximately RMB 1.0 million, a turnaround from a net loss of approximately RMB 4.1 million in the previous year, representing a difference of about RMB 5.1 million[27]. - The overall gross profit margin increased from approximately 34.8% in the previous year to about 36.9% in the current period[27]. - The group recorded total revenue of approximately RMB 66.0 million, an increase of approximately RMB 6.3 million or 10.5% compared to RMB 59.7 million in the same period last year[34]. - Gross profit increased to approximately RMB 24.3 million, an increase of approximately RMB 3.5 million or 17.2% from approximately RMB 20.8 million in the same period last year[38]. - Net profit for the period was approximately RMB 1.0 million, a turnaround from a net loss of approximately RMB 4.1 million in the same period last year, resulting in a net profit margin of approximately 1.6%[44]. Revenue Segmentation - Revenue from the household hygiene products segment increased to approximately RMB 38.5 million, up approximately RMB 10.2 million or 36.1% from approximately RMB 28.3 million in the same period last year[34]. - Revenue from the oral care products segment decreased to approximately RMB 23.5 million, down approximately RMB 4.0 million or 14.6% from approximately RMB 27.5 million in the same period last year[34]. Cost Management - Selling and distribution costs decreased to approximately RMB 12.3 million, down approximately RMB 0.4 million or 3.5% from approximately RMB 12.8 million in the same period last year[39]. - Administrative expenses increased to approximately RMB 13.5 million, an increase of approximately RMB 0.7 million or 5.1% from approximately RMB 12.8 million in the same period last year[40]. - Interest expenses decreased to approximately RMB 131,000, down approximately RMB 117,000 or 47.2% from approximately RMB 248,000 in the same period last year[41]. - The financing costs decreased to RMB 131,000 in Q1 2023 from RMB 248,000 in Q1 2022, indicating improved financial management[4]. Tax and Other Income - The company incurred a tax credit of RMB 1,548,000 in Q1 2023, compared to RMB 403,000 in the same period last year, showing a positive trend in tax management[4]. - The income tax expense for the current period included current tax of RMB 1,567 thousand and deferred tax of RMB (19) thousand, totaling RMB 1,548 thousand[18]. - The company reported other income of RMB 1,116,000 in Q1 2023, compared to RMB 648,000 in the same period last year, reflecting a growth of 72.2%[4]. Corporate Governance and Compliance - The audit committee, consisting of three independent non-executive directors, has reviewed the unaudited consolidated performance for the period and confirmed compliance with applicable accounting standards and GEM listing rules[65]. - The company maintains sufficient public float as required by GEM listing rules from the listing date to the report date[67]. - The company has complied with the corporate governance code as per GEM listing rules during the reporting period[66]. - The company has confirmed that all directors have complied with the trading code during the reporting period[59]. Future Outlook and Strategic Initiatives - The company plans to establish a dedicated team for toothpaste filing management in response to regulatory changes[30]. - The company aims to enhance its product competitiveness by improving production capacity and technical leadership, especially in oral care products[32]. - The company anticipates opportunities and challenges in the second quarter of 2023 due to the gradual reduction of pandemic impacts on the Chinese economy[29]. - The company expects that changes in Chinese regulations regarding cosmetic labeling and toothpaste management will introduce uncertainties in the promotion and sales of oral care products[29]. Dividend Policy - The company did not recommend any dividend payment for the current period, consistent with the previous year[26]. - The board has resolved not to declare any dividends for the period, consistent with the previous year[45]. Shareholder and Securities Information - The company has confirmed that no directors or controlling shareholders have any interests in competing businesses during the reporting period[61]. - The company has not granted any rights to directors or their immediate family members to benefit from purchasing the company's shares or debt securities during the reporting period[56]. - No purchases, sales, or redemptions of the company's listed securities have occurred during the reporting period[57]. - The company has published its quarterly performance announcement and report, which can be accessed on the Hong Kong Stock Exchange website and the company's website[69].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全 部或任何部份內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 China Golden Classic Group Limited 中 國 金 典 集 團 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：8281） 二 零 二 三 年 第 一 季 度 業 績 公 告 香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為相比起其他在聯交所上市的公司帶有較高投資風險的中小 型公司提供一個上市的市場。有意投資的人士應瞭解投資於該等公司的潛在 風險，並應經過審慎周詳的考慮後方作出投資決定。 由於在GEM上市的公司普遍為中小型公司，在GEM買賣的證券可能會較於主 板買賣的證券承受較大的市場波動風險，同時無法保證在GEM買賣的證券會 有高流通量的市場。 本公告乃根據聯交所GEM證券上市規則（「GEM上市規則」）之規定提供有關中國 金典集團有限公司（「本公司」及連同其附屬公司（「本集團」））之資料。本公司各 董事（「董事」）共同及個別對本公告承擔全部 ...

Financial Performance - The group's revenue for the fiscal year ended December 31, 2022, was approximately RMB 270.5 million, a decrease of about 8.5% from approximately RMB 295.7 million in the previous year[11]. - The gross profit margin decreased from approximately 39.1% to about 37.6%, reflecting increased promotional efforts to maintain market share[11]. - The net profit for the year was approximately RMB 12.2 million, a decrease of about 5.4% compared to the previous year, with a net profit margin of approximately 4.5%, up from 4.3%[11]. - Revenue from household hygiene products for the year was approximately RMB 142.6 million, down from RMB 151.5 million in the previous year[13]. - Revenue from oral care products decreased by approximately RMB 12.6 million or 10.3% to RMB 109.6 million, primarily due to reduced foot traffic in physical retail stores in China and weak demand on online platforms[24]. - Revenue from household hygiene products decreased by approximately RMB 8.9 million or 5.9% to RMB 142.6 million, mainly impacted by COVID-19[24]. - Gross profit decreased by approximately 12.2% to about RMB 101.6 million, with a gross profit margin of approximately 37.6%, down from 39.1% in the previous year[28][29]. - Selling and distribution costs decreased by approximately RMB 13.0 million or 22.1% to RMB 45.9 million, attributed to reduced promotional expenses and temporary sales personnel costs[30]. - Administrative expenses slightly increased by approximately RMB 1.1 million or 2.4% to RMB 47.4 million, driven by increased business entertainment and management salaries[31]. Dividend and Shareholder Information - The board proposed a final dividend of RMB 0.005 per share, compared to no dividend in the previous year[17]. - The total amount of the proposed final dividend is approximately RMB 5,000,000[92]. - The company has adopted a dividend policy in accordance with the GEM Listing Rules, which will consider financial performance, cash flow, and overall business conditions before declaring dividends[91]. - The company will suspend the registration of shareholders from May 31 to June 1, 2023, for the purpose of determining eligibility for the final dividend[96]. - As of December 31, 2022, the company's distributable reserves amounted to approximately RMB 121.7 million, which includes share premium and other reserves after deducting accumulated losses[124]. Operational Challenges and Future Outlook - The company faced significant operational challenges due to COVID-19, impacting supply chains and workforce availability throughout the year[11]. - The company expects a stable recovery in the Chinese economy in 2023, despite ongoing global economic challenges[18]. - The management team remains committed to expanding operations in the oral care and household hygiene sectors to create shareholder value[18]. - The group has implemented measures to mitigate supply chain risks, including increasing inventory levels and enhancing online sales performance[54]. - A new kitchen and bathroom cleaning product is set to be launched, anticipated to become a new growth point for the company[18]. Governance and Management - The board of directors is responsible for independent oversight of the group's management, ensuring compliance with governance standards[87]. - The group has maintained a consistent approach to corporate governance, ensuring transparency and accountability in its operations[91]. - The company has established a remuneration committee to review the remuneration policies and structures for directors and senior management[152]. - The board consists of three executive directors and three independent non-executive directors, ensuring a balanced governance structure[174]. - The company has established specific committees, including the Audit Committee, Remuneration Committee, and Nomination Committee, to enhance governance effectiveness[184]. - The governance policies and practices are regularly reviewed to ensure compliance with legal and regulatory requirements[185]. Risk Management and Compliance - The group faced no significant foreign exchange risk as most sales and production costs are settled in RMB, with limited expenses in USD and HKD[48]. - The group has no formal foreign exchange hedging policy and has not engaged in hedging activities during the year[55]. - The group has implemented internal guidelines for risk management and financial performance review, ensuring strategic oversight[177]. - The Audit Committee confirmed that the annual report complies with GEM listing rules[189]. Employee and Community Engagement - The total employee cost for the year was approximately RMB 27.0 million, a decrease from RMB 27.3 million in 2021, primarily due to reduced sales and marketing[49]. - The group had a total of 266 employees as of December 31, 2022, a slight decrease from 268 employees in 2021[152]. - The group made charitable donations totaling RMB 325,000 during the year, down from RMB 430,000 in the previous year[157]. Financial Position and Equity - The company's total equity as of December 31, 2022, was approximately RMB 260.2 million, an increase from RMB 248.0 million in the previous year[37]. - The debt-to-equity ratio as of December 31, 2022, was approximately 5.8%, a decrease from 6.0% in the previous year, due to an increase in total equity[43]. - The company had outstanding bank loans of approximately RMB 15.0 million as of December 31, 2022, unchanged from the previous year[38]. - As of December 31, 2022, the group had approximately RMB 70.4 million in financial liabilities due within the next 12 months, with net current assets of approximately RMB 83.7 million[58]. Share Option Scheme - The company adopted a share option scheme on June 17, 2016, aimed at attracting and retaining top personnel and providing additional incentives to employees and partners[137]. - The maximum number of shares involved in the share option plan shall not exceed 10% of the total issued shares as of the company's listing date, which amounts to 100,000,000 shares[140]. - Each participant's allocation limit under any share option plan shall not exceed 1% of the issued shares within any 12-month period[141]. - The share option plan will be valid for ten years from the adoption date, with approximately three years remaining as of the report date[149]. - The share option plan does not have performance targets that must be met before exercising any options[145].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全 部或任何部份內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 China Golden Classic Group Limited 中 國 金 典 集 團 有 限 公 司 （於開曼群島註冊成立之有限公司） （股份代號：8281） 截 至 二 零 二 二 年 十 二 月 三 十 一 日 止 年 度 之 年 度 業 績 公 告 香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為相比起其他在聯交所上市的公司帶有較高投資風險的中小 型公司提供一個上市的市場。有意投資的人士應瞭解投資於該等公司的潛在 風險，並應經過審慎周詳的考慮後方作出投資決定。 由於GEM上市的公司普遍為中小型公司，在GEM買賣的證券可能會較於聯交 所主板買賣的證券承受較大的市場波動風險，同時無法保證在GEM買賣的證 券會有高流通量的市場。 香港交易及結算所有限公司及聯交所對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內 容而產生或因倚 ...

Financial Performance - Revenue for the third quarter of 2022 was RMB 71,281,000, a decrease of 6.3% compared to RMB 76,418,000 in the same period of 2021[7] - Gross profit for the third quarter of 2022 was RMB 26,963,000, down 7.7% from RMB 29,217,000 in the third quarter of 2021[7] - The net profit for the third quarter of 2022 was RMB 3,309,000, a decrease of 20.1% compared to RMB 4,143,000 in the same period of 2021[7] - Basic and diluted earnings per share for the third quarter of 2022 were RMB 0.33, down from RMB 0.41 in the third quarter of 2021[7] - Total comprehensive income for the third quarter of 2022 was RMB 3,500,000, compared to RMB 4,283,000 in the same period of 2021, reflecting a decrease of 18.2%[7] - The total revenue for the nine months ended September 30, 2022, was RMB 186,203,000, a decrease of 9.2% from RMB 204,861,000 in the same period of 2021[7] - The gross profit for the nine months ended September 30, 2022, was RMB 68,397,000, down 14.4% from RMB 79,904,000 in the same period of 2021[7] - The company reported a net profit of RMB 1,802,000 for the nine months ended September 30, 2022, compared to RMB 3,361,000 in the same period of 2021, representing a decline of 46.5%[7] - Total revenue for the nine months ended September 30, 2022, was RMB 186,203 thousand, a decrease of 9.1% compared to RMB 204,861 thousand for the same period in 2021[28][31] - Net profit attributable to owners for the nine months ended September 30, 2022, was RMB 1,802 thousand, a decline of 46.4% from RMB 3,361 thousand in the same period of 2021[41][45] - Basic earnings per share for the nine months ended September 30, 2022, was RMB 0.0018, compared to RMB 0.0034 for the same period in 2021[42][45] - The net profit for the period was approximately RMB 1.8 million, down about 46.4% from RMB 3.4 million in the previous year, resulting in a net profit margin of 1.0%, down from 1.6%[55][65] - The overall gross profit margin decreased to approximately 36.7%, down 2.3 percentage points from 39.0% in the previous year[58] Revenue Breakdown - Oral care products generated revenue of RMB 82,968 thousand, down 6.4% from RMB 88,776 thousand in the previous year[28][31] - Household hygiene products revenue was RMB 92,164 thousand, a decrease of 10.3% from RMB 102,714 thousand in the same period last year[28][31] - Leather care products revenue fell to RMB 11,071 thousand, down 17.1% from RMB 13,371 thousand year-over-year[28][31] - Revenue from oral care products decreased by approximately 6.5% to RMB 83.0 million, while revenue from household hygiene products decreased by 17.2% to RMB 92.2 million, primarily due to weak demand from distributors affected by the pandemic[56] Expenses and Costs - The company’s financing costs for the third quarter of 2022 were RMB 248,000, an increase from RMB 166,000 in the same period of 2021[7] - Sales and distribution costs decreased by approximately RMB 8.4 million or 19.4% to RMB 35.0 million, mainly due to a reduction in temporary sales personnel costs[61] - Administrative expenses slightly decreased by approximately RMB 0.5 million or 1.5% to RMB 33.2 million, attributed to lower maintenance and consultancy costs compared to the previous year[62] - Interest expenses for the period were approximately RMB 0.5 million, a decrease of about 7.7% from RMB 0.6 million in the previous year, mainly due to a reduction in loan amounts[63][64] Dividends and Shareholder Information - The company did not recommend any dividend for the nine months ended September 30, 2022, consistent with the previous year[46] - The company does not recommend the distribution of any dividends for the period[66] - Major shareholder Zhongbao Mali holds 575,625,000 shares, representing 57.56% of the company's equity[75] - Tongxing Holdings owns 106,875,000 shares, accounting for 10.69% of the company's equity[75] - The company has not granted any stock options under its stock option plan since its adoption in June 2016[80] Future Plans and Strategies - The company plans to continue focusing on the development of oral care, leather care, and household hygiene products to drive future growth[21] - The company plans to strengthen its epidemic prevention measures and optimize its supply chain system to prepare sufficient goods for distributors in lockdown areas[51] - The company aims to invest more resources to enhance connections with companies looking to develop the bio-oral care product market[51] Compliance and Audit - The audit committee has reviewed the unaudited consolidated results for the period and confirmed compliance with applicable accounting standards[88] - The company has maintained sufficient public float as required by GEM listing rules since its listing date[93] Depreciation and Tax - The company reported a total tax expense of RMB 1,828 thousand for the nine months ended September 30, 2022[38] - The depreciation of property, plant, and equipment for the nine months was RMB 8,035 thousand, down from RMB 9,566 thousand in the previous year[41][45] Product Development - The company has not identified any new products or technologies in the current report, focusing instead on existing product lines[25][26]

Financial Performance - For the six months ended June 30, 2022, the company reported revenue of RMB 114,922,000, a decrease of 10.5% compared to RMB 128,443,000 for the same period in 2021[21] - Gross profit for the same period was RMB 41,434,000, down 18% from RMB 50,687,000 in the previous year[21] - The company recorded a net loss of RMB 1,507,000 for the six months ended June 30, 2022, compared to a net loss of RMB 782,000 for the same period in 2021[21] - Total revenue from the oral care products segment for the six months ended June 30, 2022, was RMB 52,744,000, down from RMB 56,812,000 in the same period of 2021, reflecting a decrease of approximately 7.5%[41] - Total revenue from the leather care products segment for the six months ended June 30, 2022, was RMB 6,081,000, down from RMB 8,961,000 in the same period of 2021, indicating a decline of approximately 32.5%[41] - Total revenue from the household hygiene products segment for the six months ended June 30, 2022, was RMB 56,097,000, down from RMB 62,670,000 in the same period of 2021, representing a decrease of approximately 10.4%[41] - The total loss before tax for the six months ended June 30, 2022, was RMB (1,574,000), compared to a loss of RMB (847,000) for the same period in 2021, indicating a worsening financial performance[41] - The company reported a net loss attributable to owners of RMB 1,507,000 for the six months ended June 30, 2022, compared to a loss of RMB 782,000 in the same period of 2021[60] - The overall gross margin for the period was approximately 36.1%, down from 39.5% in the same period last year, a decrease of about 3.4%[103] Cash Flow and Assets - The company's cash and cash equivalents decreased to RMB 31,291,000 from RMB 68,596,000 at the end of 2021[23] - Net cash used in operating activities for the six months ended June 30, 2022, was RMB (26,358,000), compared to RMB (22,619,000) for the same period in 2021, indicating a decline in cash flow from operations[27] - Cash and cash equivalents decreased by RMB 38,146,000 during the six months ended June 30, 2022, compared to a decrease of RMB 25,640,000 in the same period of 2021[27] - The cash balance at the end of the period was RMB 31,291,000, down from RMB 49,455,000 at the end of the same period in 2021, reflecting a decline of approximately 36.7%[27] - Total assets as of June 30, 2022, were RMB 248,666,000, slightly down from RMB 249,268,000 as of December 31, 2021[23] - Total assets as of June 30, 2022, were RMB 308,573,000, a decrease of 12.6% from RMB 353,015,000 as of December 31, 2021[52] Inventory and Receivables - Inventory increased to RMB 38,926,000 as of June 30, 2022, from RMB 32,560,000 at the end of 2021[23] - As of June 30, 2022, trade receivables amounted to RMB 34,641,000, a decrease of 28.5% from RMB 48,448,000 as of December 31, 2021[10] - The aging analysis of trade receivables shows that amounts overdue by 0 to 30 days decreased to RMB 30,748,000 from RMB 40,735,000, representing a decline of 24.5%[74] - The total trade and other payables as of June 30, 2022, were RMB 41,095,000, down 27.8% from RMB 56,865,000 as of December 31, 2021[82] Management and Strategy - The company plans to focus on expanding its market presence and enhancing product development in the upcoming quarters[19] - The management highlighted ongoing efforts in research and development for new products and technologies to drive future growth[19] - The company plans to enhance the development of enzyme-based biocidal products to increase market share in household hygiene products[98] Employee and Compensation - The group employed 264 full-time employees, with employee costs amounting to approximately RMB 7.9 million during the period[118] - The total compensation for directors and key management personnel was RMB 764,000 for the six months ended June 30, 2022, down from RMB 823,000 in the same period of the previous year[91] Dividends and Shareholder Information - The company did not declare any dividends for the six months ended June 30, 2022, consistent with the previous year[64] - The company does not recommend the payment of an interim dividend for the period[110] - Major shareholders include Zhongbao Mali with a 57.56% stake and Tongxing Holdings with a 10.69% stake as of June 30, 2022[126] Compliance and Governance - The audit committee, consisting of three independent non-executive directors, has reviewed the unaudited consolidated results for the six months ending June 30, 2022, and confirmed compliance with applicable accounting standards and GEM Listing Rules[137] - The company has maintained sufficient public float as required by GEM Listing Rules since the listing date[140] - The interim results announcement and report for the six months ending June 30, 2022, are available on the Hong Kong Stock Exchange website and the company's website[140]

Financial Performance - The company's revenue for the first quarter of 2022 was RMB 59,724,000, a decrease of 12.5% compared to RMB 68,259,000 in the same period last year[5] - Gross profit for the first quarter was RMB 20,764,000, down from RMB 27,010,000 year-on-year, reflecting a gross margin decline[5] - The company reported a loss before tax of RMB 4,475,000, compared to a loss of RMB 3,680,000 in the previous year[5] - The net loss for the period was RMB 4,072,000, compared to a net loss of RMB 2,945,000 in the same quarter last year[5] - Basic and diluted loss per share was RMB 0.41, compared to RMB 0.29 in the previous year[5] - The company recorded a revenue of approximately RMB 597 million for the first quarter, a decrease of about 12.5% compared to RMB 683 million in the same period last year[28] - The net loss for the first quarter was approximately RMB 41 million, an increase of about RMB 11 million or 38.3% from the net loss of RMB 29 million in the previous year[28] - The gross profit margin decreased from approximately 39.5% in the previous year to about 34.8% in the current period[28] - The net loss margin for the first quarter was approximately 6.8%, compared to 4.3% in the same period last year, reflecting a difference of about 2.5%[28] - The basic loss per share for the first quarter was RMB 0.41, compared to RMB 0.29 in the same period last year[34] - The group recorded total revenue of approximately RMB 59.7 million, a decrease of about RMB 8.5 million or 12.5% compared to the same period last year[35] - The group incurred a net loss of approximately RMB 4.1 million, an increase of RMB 1.1 million or 38.3% compared to a net loss of RMB 2.9 million in the same period last year[42] - The net loss margin for the period was approximately 6.8%, compared to 4.3% in the same period last year, reflecting a difference of about 2.5%[42] Revenue Breakdown - Revenue from oral care products was RMB 27,507,000, leather care products contributed RMB 3,954,000, and hygiene products generated RMB 28,263,000, totaling RMB 59,724,000[15] - Revenue from household hygiene products decreased by approximately RMB 5.3 million or 15.8% to RMB 28.3 million, while leather care products saw a decline of approximately RMB 1.7 million or 30.4% to RMB 4.0 million[35] Operational Challenges - The company faced significant operational challenges due to COVID-19, including supply chain disruptions and weakened demand from distributors[29] - The management has implemented a series of strategies to address the challenges, including establishing a professional team for epidemic prevention and control measures[29] - The company remains optimistic about future prospects, citing recovery trends in various regions and increased consumer awareness of hygiene products[31] - The company has been allowed to resume operations under a closed management model, with daily nucleic acid testing for all employees[31] Expenses and Investments - Selling and distribution expenses were approximately RMB 12.8 million, a decrease of about RMB 7.6 million or 37.3% compared to the previous year[39] - Administrative expenses increased to approximately RMB 12.8 million, up RMB 2.6 million or 24.8% due to increased depreciation of property, plant, and equipment[40] - There were no significant investments, acquisitions, or disposals of subsidiaries during the period[43] - The company has no plans for significant investments or capital assets as of March 31, 2022[43] Corporate Governance - The company has established an audit committee in accordance with GEM listing rules, which includes three independent non-executive directors[61] - The company has adopted the corporate governance code as per GEM listing rules and has complied with its provisions during the reporting period[62] - The company maintains sufficient public float as required by GEM listing rules since its listing date[65] Dividends and Share Options - The company did not declare any dividends for the first quarter, consistent with the previous year[25] - The company has adopted a stock option plan effective for 10 years from June 17, 2016, to reward selected participants for their contributions[54] - No directors or their immediate family members have been granted rights to acquire shares or debentures of the company during the reporting period[55] - The company and its subsidiaries have not purchased, sold, or redeemed any listed securities during the reporting period[56]

Financial Performance - The group's revenue for the year ended December 31 decreased by approximately 3.3% to RMB 295.7 million from RMB 305.8 million in the previous year[22]. - The gross profit margin declined to approximately 39.1% from 43.3% in the previous year[22]. - The net profit for the year was approximately RMB 12.8 million, a decrease of about 29.3% compared to the previous year, with a net profit margin of approximately 4.3%[22]. - The net profit margin decreased by approximately 1.6% from the previous year, which was 5.9%[22]. - Sales revenue from oral care products decreased by approximately RMB 32.4 million or 21.0% to RMB 122.2 million due to reduced foot traffic in physical retail stores[34]. - Revenue from household hygiene products increased by approximately RMB 21.5 million or 16.6% to RMB 151.5 million, driven by increased promotion efforts[34]. - The company does not recommend the payment of a final dividend for the current year due to the profit level, consistent with the previous year where no dividend was paid[102]. Research and Development - The company has launched a new IoT-based workshop for household hygiene products, which has been included in the Wuxi New Generation Information Technology Special Fund Directory[22]. - The company has increased investment in R&D for household hygiene products to meet rising consumer demand[22]. - The R&D department is led by a qualified engineer with over 20 years of experience in the industry, focusing on technological advancements[96]. Corporate Governance - The company is committed to enhancing its corporate governance and compliance with listing regulations, as evidenced by the appointment of a qualified company secretary[95]. - The board of directors includes members with significant experience in various sectors, contributing to informed decision-making and strategic planning[90][92]. - The independent non-executive directors bring diverse expertise, with backgrounds in education administration and accounting, enhancing the group's governance[90][92]. - The company has established specific committees, including the audit, remuneration, and nomination committees, to enhance governance practices[186]. - The audit committee reviewed the group's financial performance for the year ending December 31, 2021, and confirmed compliance with GEM listing rules[191]. - The remuneration committee assessed the compensation schemes for directors and senior management, deeming them fair and reasonable[194]. Financial Position - As of December 31, 2021, the total equity of the group was approximately RMB 248.0 million, an increase from RMB 235.5 million in 2020[48]. - The group's current assets were approximately RMB 180.4 million, down from RMB 189.0 million in 2020, while current liabilities decreased to approximately RMB 103.7 million from RMB 122.2 million[48]. - The current ratio improved to 1.74 in 2021 from 1.55 in 2020[48]. - The group had outstanding bank borrowings of approximately RMB 15.0 million as of December 31, 2021, down from RMB 20.0 million in 2020[49]. - The debt-to-equity ratio was approximately 6.0% as of December 31, 2021, a decrease from 8.5% in 2020, primarily due to a reduction in average outstanding loans[55]. - The group maintained a cash balance of approximately RMB 68.6 million as of December 31, 2021, down from RMB 74.7 million in 2020[49]. Market Strategy - The company plans to enhance its market share in nursing products and expand sales in Northeast and North China regions[34]. - The company will participate in the Shanghai Beauty Expo to expand its OEM market for hygiene products[34]. - The company aims to strengthen long-term agreements with key suppliers to mitigate the impact of raw material price fluctuations on gross margins[34]. Employee and Social Responsibility - Employee costs for the year were approximately RMB 27.3 million, a decrease from RMB 28.1 million in 2020, attributed to reduced sales and marketing expenses[62]. - Charitable donations made by the group amounted to RMB 430,000 in the current year, compared to RMB 205,000 in the previous year[158]. - The group is committed to enhancing employee awareness of environmental protection through regular training[75]. Compliance and Risk Management - The group has complied with all applicable environmental protection laws and regulations in China during the year[75]. - The group has not faced any significant violations of applicable laws and regulations during the year[76]. - The group has maintained a low credit risk due to deposits in banks with high credit ratings from international credit rating agencies[71]. - The group has a strategy to manage liquidity risk by maintaining sufficient cash and bank financing[72]. Shareholder Information - As of December 31, 2021, major shareholders include 中寶瑪儷 with 575,625,000 shares (57.56%) and 童星控股 with 106,875,000 shares (10.69%)[140]. - The company has a share option plan that allows for a maximum of 100,000,000 shares to be granted, representing 10% of the total issued shares at the time of the report[145]. - The company has not granted any stock options under the stock option plan since its adoption[152]. - The company has not engaged in any significant acquisitions, sales, or investments during the year[117].

China Golden Classic Group Limited 中 國 金 典 集 團 有 限 公 司 (於開曼群島註冊成立之有限公司) 股份代號：8281 VIT / 元 '雪 狗 第三季度報告 2021 香港聯合交易所有限公司（「聯交所」）GEM（「GEM」）之特色 GEM的定位，乃為中小型公司提供一個上市的市場，此等公司相比起其他在主板 上市的公司帶有較高投資風險。有意投資的人士應了解投資於該等公司的潛在風 險，並應經過審慎周詳的考慮後方作出投資決定。 由於GEM上市公司普遍為中小型公司，在GEM買賣的證券可能會較於主板買賣之 證券承受較大的市場波動風險，同時無法保證在GEM買賣的證券會有高流通量的 市場。 香港交易及結算所有限公司及聯交所對本報告之內容概不負責，對其準確性或完 整性亦不發表任何聲明，並明確表示概不就因本報告全部或任何部分內容而產生 或因依賴該等內容而引致之任何損失承擔任何責任。 | --- | --- | |--------------------------------------------------------------------------------------- ...